Birzeit Pharmaceuticals Company (PEX:BPC)

Palestine flag Palestine · Delayed Price · Currency is JOD · Price in USD
4.000
0.00 (0.00%)
At close: Dec 1, 2025
7.24%
Market Cap 109.92M
Revenue (ttm) 33.00M
Net Income (ttm) 9.09M
Shares Out 38.76M
EPS (ttm) 0.23
PE Ratio 12.07
Forward PE n/a
Dividend 0.04 (1.25%)
Ex-Dividend Date Apr 23, 2025
Volume 74,014
Average Volume 9,310
Open 3.970
Previous Close n/a
Day's Range 3.900 - 4.000
52-Week Range 3.550 - 4.350
Beta -0.05
RSI 65.21
Earnings Date Nov 12, 2025

About PEX:BPC

Birzeit Pharmaceuticals Company manufactures and trades in various medicines in the Palestinian Authority. The company offers its products in various therapeutic fields comprising alimentary system, cardio-vascular system, muscolo-skeletal system, endocrines, central nervous system, genito-urinary system, obstetrics and gynecology, infections, dermatological preparations, ophthalmic drugs, respiratory system, and nutrition and metabolism, as well as ear, nose, and oropharynx. It also provides OTC products, such as multivitamins and minerals, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1973
Employees 300
Stock Exchange Palestine Stock Exchange
Ticker Symbol BPC
Full Company Profile

Financial Performance

In 2024, PEX:BPC's revenue was $40.65 million, a decrease of -5.74% compared to the previous year's $43.13 million. Earnings were $5.18 million, a decrease of -15.26%.

Financial numbers in USD Financial Statements

News

There is no news available yet.